MARKSANS PHARMA LIMITED

MARKSANS

Small Cap | Pharmaceuticals
177.36
-2.19 (-1.21%)

Stock price as on 06 Feb 2026 at 15:30 PM

Marksans pharma limited share price update

As of the latest trading session, Marksans Pharma Limited share price is currently at ₹177.36, which is down by ₹-2.19 from its previous closing. Toda...

Marksans Pharma Limited stock performance

Today’s low

₹171.7

Today’s high

₹179.57

₹177.36

52 week low

₹156

52 week high

₹276.4

₹177.36
Open
₹179.57
Previous close
₹179.55
Share volume
10,47,646
Total traded value (Lakh)
₹1,858.10
Upper circuit
₹215.46
Lower circuit
₹143.64

Marksans Pharma Limited fundamentals

Market cap (Cr)
₹8,037.30
P/E ratio (TTM)
33.75
Book value per share
₹32.99
Beta
1.39
Return on equity
14.45%
Earnings per share (TTM)
₹5.32
Dividend yield
0.45%
Net profit/quarter (Cr)
₹60.91

Marksans Pharma Limited financials

(Values in Cr)
Revenue
Net income

Particulars

Dec 25 (₹ value in crores)

Revenue

₹339.73

Operating expense

₹273.47

Net income

₹60.91

Net profit margin

17.92%

Earning per share

₹1.34

EBITDA

₹91.31

Effective tax rate

25.81%

Particulars

Sep 25 (₹ value in crores)

Revenue

₹320.44

Operating expense

₹257.14

Net income

₹99.81

Net profit margin

31.14%

Earning per share

₹2.20

EBITDA

₹130.26

Effective tax rate

17.85%

Particulars

Jun 25 (₹ value in crores)

Revenue

₹319.73

Operating expense

₹258.17

Net income

₹48.06

Net profit margin

15.03%

Earning per share

₹1.06

EBITDA

₹72.06

Effective tax rate

24.41%

Particulars

Mar 25 (₹ value in crores)

Revenue

₹299.36

Operating expense

₹256.09

Net income

₹37.59

Net profit margin

12.55%

Earning per share

₹0.83

EBITDA

₹58.39

Effective tax rate

24.66%

Particulars

Dec 24 (₹ value in crores)

Revenue

₹311.87

Operating expense

₹259.65

Net income

₹55.46

Net profit margin

17.78%

Earning per share

₹1.22

EBITDA

₹82.44

Effective tax rate

25.77%

(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Revenue

₹1,174.37

Operating expense

₹996.90

Net income

₹188.27

Net profit margin

16.03%

Earning per share

₹4.15

EBITDA

₹273.88

Effective tax rate

22.6%

Particulars

Mar 24 (₹ value in crores)

Revenue

₹853.27

Operating expense

₹743.46

Net income

₹133.76

Net profit margin

15.67%

Earning per share

₹2.95

EBITDA

₹202.01

Effective tax rate

22.18%

Particulars

Mar 23 (₹ value in crores)

Revenue

₹655.20

Operating expense

₹583.65

Net income

₹102.87

Net profit margin

15.7%

Earning per share

₹2.48

EBITDA

₹152.39

Effective tax rate

22.09%

Particulars

Mar 22 (₹ value in crores)

Revenue

₹658.29

Operating expense

₹566.04

Net income

₹103.99

Net profit margin

15.79%

Earning per share

₹2.54

EBITDA

₹155.97

Effective tax rate

22.68%

Particulars

Mar 21 (₹ value in crores)

Revenue

₹599.55

Operating expense

₹506.38

Net income

₹98.38

Net profit margin

16.4%

Earning per share

₹2.40

EBITDA

₹144.87

Effective tax rate

20.87%

(Values in Cr)
Revenue
Net income

Particulars (annual)

Mar 25 (₹ value in crores)

Book value per share

₹54.44

Return on Equity (ROE)

16.89%

Return on Capital Employed (ROCE)

20.19%

Total debt to equity ratio

0.12

EBITDA margin

22.84%

Particulars (annual)

Mar 24 (₹ value in crores)

Book value per share

₹45.57

Return on Equity (ROE)

16.53%

Return on Capital Employed (ROCE)

20.78%

Total debt to equity ratio

0.1

EBITDA margin

23.38%

Particulars (annual)

Mar 23 (₹ value in crores)

Book value per share

₹38.51

Return on Equity (ROE)

18%

Return on Capital Employed (ROCE)

21.77%

Total debt to equity ratio

0.08

EBITDA margin

21.52%

Particulars (annual)

Mar 22 (₹ value in crores)

Book value per share

₹27.10

Return on Equity (ROE)

17.89%

Return on Capital Employed (ROCE)

22.83%

Total debt to equity ratio

0.07

EBITDA margin

20.17%

Particulars (annual)

Mar 21 (₹ value in crores)

Book value per share

₹21.66

Return on Equity (ROE)

31.34%

Return on Capital Employed (ROCE)

38.77%

Total debt to equity ratio

0.04

EBITDA margin

25.16%

(Values in Cr)
Revenue
Net income

Particulars (annual)

Mar 25 (₹ value in crores)

Book value per share

₹30.53

Return on Equity (ROE)

14.45%

Return on Capital Employed (ROCE)

18.55%

Total debt to equity ratio

0.01

EBITDA margin

23.32%

Particulars (annual)

Mar 24 (₹ value in crores)

Book value per share

₹26.98

Return on Equity (ROE)

11.46%

Return on Capital Employed (ROCE)

14.67%

Total debt to equity ratio

0.01

EBITDA margin

23.67%

Particulars (annual)

Mar 23 (₹ value in crores)

Book value per share

₹24.52

Return on Equity (ROE)

10.85%

Return on Capital Employed (ROCE)

14.11%

Total debt to equity ratio

0.01

EBITDA margin

23.26%

Particulars (annual)

Mar 22 (₹ value in crores)

Book value per share

₹16.90

Return on Equity (ROE)

15.02%

Return on Capital Employed (ROCE)

19.45%

Total debt to equity ratio

0.02

EBITDA margin

23.69%

Particulars (annual)

Mar 21 (₹ value in crores)

Book value per share

₹14.65

Return on Equity (ROE)

17.29%

Return on Capital Employed (ROCE)

22.04%

Total debt to equity ratio

0.02

EBITDA margin

24.16%

(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Cash and short term investments

₹704.20

Total assets

₹3,239.63

Total liabilities

₹3,239.63

Total equity

₹2,489.38

Shares outstanding

₹45.31

Price to book ratio

₹7.28

Return on assets (%)

11.74%

Return on capital

15.15%

Particulars

Mar 24 (₹ value in crores)

Cash and short term investments

₹673.57

Total assets

₹2,680.95

Total liabilities

₹2,680.95

Total equity

₹2,085.90

Shares outstanding

₹45.31

Price to book ratio

₹5.62

Return on assets (%)

11.7%

Return on capital

14.83%

Particulars

Mar 23 (₹ value in crores)

Cash and short term investments

₹714.96

Total assets

₹2,190.38

Total liabilities

₹2,190.38

Total equity

₹1,765.07

Shares outstanding

₹45.31

Price to book ratio

₹2.87

Return on assets (%)

12.15%

Return on capital

14.74%

Particulars

Mar 22 (₹ value in crores)

Cash and short term investments

₹349.26

Total assets

₹1,640.10

Total liabilities

₹1,640.10

Total equity

₹1,222.97

Shares outstanding

₹40.93

Price to book ratio

₹2.70

Return on assets (%)

11.25%

Return on capital

14.6%

Particulars

Mar 21 (₹ value in crores)

Cash and short term investments

₹212.18

Total assets

₹1,228.81

Total liabilities

₹1,228.81

Total equity

₹905.35

Shares outstanding

₹40.93

Price to book ratio

₹3.41

Return on assets (%)

19.2%

Return on capital

25.53%

(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Cash and short term investments

₹268.69

Total assets

₹1,755.30

Total liabilities

₹1,755.30

Total equity

₹1,383.48

Shares outstanding

₹45.31

Price to book ratio

₹7.28

Return on assets (%)

10.72%

Return on capital

13.61%

Particulars

Mar 24 (₹ value in crores)

Cash and short term investments

₹312.22

Total assets

₹1,516.03

Total liabilities

₹1,516.03

Total equity

₹1,222.70

Shares outstanding

₹45.31

Price to book ratio

₹5.62

Return on assets (%)

8.82%

Return on capital

10.94%

Particulars

Mar 23 (₹ value in crores)

Cash and short term investments

₹440.26

Total assets

₹1,344.86

Total liabilities

₹1,344.86

Total equity

₹1,111.32

Shares outstanding

₹45.31

Price to book ratio

₹2.87

Return on assets (%)

7.64%

Return on capital

9.26%

Particulars

Mar 22 (₹ value in crores)

Cash and short term investments

₹224.04

Total assets

₹965.60

Total liabilities

₹965.60

Total equity

₹784.67

Shares outstanding

₹40.93

Price to book ratio

₹2.70

Return on assets (%)

10.76%

Return on capital

13.17%

Particulars

Mar 21 (₹ value in crores)

Cash and short term investments

₹105.61

Total assets

₹740.69

Total liabilities

₹740.69

Total equity

₹599.71

Shares outstanding

₹40.93

Price to book ratio

₹3.41

Return on assets (%)

13.28%

Return on capital

16.4%

(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Net income

₹503.96

Cash from operations

₹332.56

Cash from investing

-₹49.00

Cash from financing

-₹65.14

Net change in cash

₹92.50

Free cash flow

₹505.48

Particulars

Mar 24 (₹ value in crores)

Net income

₹423.52

Cash from operations

₹352.75

Cash from investing

-₹140.84

Cash from financing

-₹68.72

Net change in cash

₹20.84

Free cash flow

₹561.59

Particulars

Mar 23 (₹ value in crores)

Net income

₹337.65

Cash from operations

₹300.42

Cash from investing

-₹259.21

Cash from financing

₹197.82

Net change in cash

₹176.02

Free cash flow

₹354.05

Particulars

Mar 22 (₹ value in crores)

Net income

₹247.51

Cash from operations

₹172.11

Cash from investing

-₹84.39

Cash from financing

₹79.51

Net change in cash

₹94.37

Free cash flow

₹218.44

Particulars

Mar 21 (₹ value in crores)

Net income

₹302.16

Cash from operations

₹227.12

Cash from investing

-₹44.84

Cash from financing

-₹15.28

Net change in cash

₹118.45

Free cash flow

₹273.54

(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Net income

₹243.25

Cash from operations

₹77.55

Cash from investing

₹17.24

Cash from financing

-₹29.91

Net change in cash

₹18.33

Free cash flow

₹197.46

Particulars

Mar 24 (₹ value in crores)

Net income

₹171.89

Cash from operations

₹72.81

Cash from investing

-₹114.22

Cash from financing

-₹26.21

Net change in cash

-₹106.38

Free cash flow

₹228.48

Particulars

Mar 23 (₹ value in crores)

Net income

₹132.03

Cash from operations

₹83.34

Cash from investing

-₹194.62

Cash from financing

₹210.01

Net change in cash

₹67.12

Free cash flow

₹118.62

Particulars

Mar 22 (₹ value in crores)

Net income

₹134.50

Cash from operations

₹87.80

Cash from investing

-₹128.06

Cash from financing

₹70.86

Net change in cash

-₹1.23

Free cash flow

₹110.65

Particulars

Mar 21 (₹ value in crores)

Net income

₹124.33

Cash from operations

₹127.13

Cash from investing

₹8.87

Cash from financing

-₹13.53

Net change in cash

₹102.26

Free cash flow

₹148.13

Marksans Pharma Limited technical summary

₹177.36
-1.21 ▼
11
Bearish
5
Bullish
5 Day175.6
10 Day172.9
12 Day172.5
20 Day172.7
26 Day173.5
50 Day176.9
100 Day184.1
200 Day195.9
5 Day173.9
10 Day168.1
12 Day168.3
20 Day170.3
26 Day172.8
50 Day179.5
100 Day179.6
200 Day203.8

179.97

PIVOT

First support
₹172.18
First resistance
₹187.33
Second support
₹164.82
Second resistance
₹195.12
Third support
₹157.03
Third resistance
₹202.48
RSI
57.34
ADX
36.89
MACD
-1.55
Williams % R
-25.83
Commodity Channel Index (CCI)
123.03
Date
05 Feb 2026
Same day
3,88,699
Week
4,20,509
Month
4,04,881
1 year
1.4
3 years
1.07
Over 1 month
-1.35%
Over 1 year
-33.49%
Over 3 months
-2.72%
Over 3 years
42.23%
Over 6 months
-20.45%
Over 6 years
24.97%

Investment Returns

Over 1 Month1.35%
Over 3 Months2.72%
Over 6 Months20.45%
Over 1 Year33.49%

Marksans Pharma Limited Shareholding pattern


Public
42.08%
Promoter holdings
43.87%
FII
8.12%
DII
5.91%
Promoter shares
0%
Promoter sharesShareCategory

Mark Saldanha

19,84,91,553 (43.8%)

Shareholding of Promoter and Promoter Group

Orbimed Asia Iv Mauritius Fvci Limited

3,90,50,881 (8.62%)

Public Shareholding

Uti-healthcare Fund

1,02,62,286 (2.26%)

Public Shareholding

Kotak Mahindra Trustee Co Ltd A/c Kotak Special Opportunities Fund

51,27,836 (1.13%)

Public Shareholding

Sandra Saldanha

3,30,456 (0.07%)

Shareholding of Promoter and Promoter Group

Promoter sharesShareCategory
Mark Saldanha19,84,91,553 (43.8%)Shareholding of Promoter and Promoter Group
Orbimed Asia Iv Mauritius Fvci Limited3,90,50,881 (8.62%)Public Shareholding
Uti-healthcare Fund1,02,62,286 (2.26%)Public Shareholding
Kotak Mahindra Trustee Co Ltd A/c Kotak Special Opportunities Fund51,27,836 (1.13%)Public Shareholding
Sandra Saldanha3,30,456 (0.07%)Shareholding of Promoter and Promoter Group

About MARKSANS PHARMA LIMITED

Marksans Pharma Limited was formerly incorporated as 'Tasc Pharmaceuticals Limited' in April, 1982. Pursuant to the Scheme of Amalgamation, name of the Company was changed from Tasc Pharmaceuticals Limited to Marksans Pharma Limited from 10th October, 2005. The Company primarily engaged in the business of research, manufacture, marketing and sale of pharmaceutical formulation. The Company's research and development facilities are located in Verna, Goa and R & D center in Navi Mumbai. In 2004-05, the Company amalgamated with M/s. Marksans Pha

Parent Organisation

Indian Private

NSE Symbol

MARKSANS

Founded

1992

MARKSANS PHARMA LIMITED CORPORATE ACTION

Dividend dateDividend amountDividend typeRecord dateInstrument type
01 Aug 20250.8Final01 Aug 2025Equity shares
17 Sept 20240.6Final17 Sept 2024Equity shares
07 Jun 20230.5Final07 Jun 2023Equity shares
19 Aug 20220.25Final23 Aug 2022Equity shares
15 Sept 20210.25Final17 Sept 2021Equity shares
22 Sept 20200.1Final24 Sept 2020Equity shares
19 Sept 20190.05Final21 Sept 2019Equity shares
19 Sept 20180.05Final22 Sept 2018Equity shares
19 Sept 20170.05Final21 Sept 2017Equity shares
22 Sept 20160.12Final24 Sept 2016Equity shares
23 Sept 20150.12Final26 Sept 2015Equity shares
18 Sept 20140.1Final20 Sept 2014Equity shares

View more stocks

What’s trending

All stocks

LOYALTEX

LOYAL TEXTILE MILLS LTD.

304.8
+50.8 (+20%)
GORANIN

GORANI INDUSTRIES LTD.

63.61
+10.6 (+20%)
NIRAJISPAT

NIRAJ ISPAT IND LTD

257.41
+42.9 (+20%)
STRATMONT

STRATMONT INDUSTRIES LIMITED

90.01
+15 (+20%)
View all

Top gainers

ITC

ITC LTD

325.8
+15.60 (+5.03%)
KOTAKBANK

KOTAK MAHINDRA BANK LTD

422.35
+13.60 (+3.33%)
HINDUNILVR

HINDUSTAN UNILEVER LTD.

2424.2
+69.80 (+2.96%)
BHARTIARTL

BHARTI AIRTEL LIMITED

2038.4
+46.00 (+2.31%)
View all

Top losers

HDFCLIFE

HDFC LIFE INS CO LTD

703.5
-17.20 (-2.39%)
TCS

TATA CONSULTANCY SERV LT

2941.6
-49.90 (-1.67%)
TECHM

TECH MAHINDRA LIMITED

1619.9
-26.30 (-1.60%)
BAJAJ-AUTO

BAJAJ AUTO LIMITED

9518.5
-128.50 (-1.33%)
View all

Frequently asked questions


Related videos


Related tags


You are here


Related links

Disclaimer

*Disclaimer for Bajaj Finance Limited (‘BFL’):

Stock trading business is carried by Bajaj Financial Securities Limited ("BFSL"), a broker and Depository Participant registered with Securities Exchange Board of India and offers various products/services related to Securities market (Securities market products/services). BFL merely facilitates display of data shared by BFSL on its webpage/mobile application. Such data received from BFSL, or any of its service providers is on “as is” basis. BFL does not make any representation or warranty, express or implied, regarding accuracy, completeness of such data displayed herein.

When you opt to avail the Securities market products/services of BFSL by clicking on the BFSL weblink/mobile app, you will be redirected to BFSL's web page/mobile app for initiation and completion of the transaction. You are supposed to exercise independent diligence by reading all the related documents carefully before deciding to invest in Securities market Products/services.

BFL is a Non-Banking Financial Company carrying the business of acceptance of deposits and providing lending solutions to Retail and Corporate customers. BFL does not offer nor advice on Securities market products/services and shall not be liable or responsible for any of your investment decision."


**Disclaimer: For Bajaj Financial Securities Limited

Investments in the securities market are subject to market risk, read all related documents carefully before investing.

Broking services offered by Bajaj Financial Securities Limited (Bajaj Broking). Reg Office: Bajaj Auto Limited Complex, Mumbai –Pune Road Akurdi Pune 411035. Corporate Office: Bajaj Financial Securities Limited, 1st Floor, Mantri IT Park, Tower B, Unit No 9 & 10, Viman Nagar, Pune, Maharashtra 411014. SEBI Registration No.: INZ000218931 | BSE Cash/F&O/CDS (Member ID:6706) | NSE Cash/F&O/CDS (Member ID: 90177) | DP registration No: IN-DP-418-2019 | CDSL DP No.: 12088600 | NSDL DP No. IN304300 | AMFI Registration No.: ARN –163403.

Details of Compliance Officer: Mr. Boudhayan Ghosh (For Broking/DP/Research) | Email: compliance_sec@bajajbroking.in | Contact No.: 020-4857 4486. For any investor grievances write to compliance_sec@bajajbroking.in/ compliance_dp@bajajbroking.in (DP related)

This content is for educational purpose only. Securities quoted are exemplary and not recommendatory.

Research Services are offered by Bajaj Broking as Research Analyst under SEBI Regn: INH000010043.

For more disclaimer, check here: https://www.bajajbroking.in/disclaimer


Powered by Bajaj Financial Securities Limited (Bajaj Broking)